Physician profile
Todd Billett
NPI 1225004096
$5,327.63
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $172 · 2021: $68.41 · 2022: $2,260 · 2023: $1,704 · 2024: $901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,170 · Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,170.00 |
| Food and Beverage | $434.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acessa Health INC. | $4,270.00 | 2022-2024 | Acessa Provu System |
| Hologic Sales and Service, LLC | $184.43 | 2021-2022 | |
| Abbvie INC. | $108.91 | 2020-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $84.20 | 2023-2024 | Veozah |
| Exeltis, USA INC. | $80.18 | 2020-2024 | Slynd |
| Pfizer INC. | $62.52 | 2019-2023 | |
| Optumhealth Care Solutions, LLC | $51.55 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Coopersurgical, INC. | $50.89 | 2019-2024 | Paragard T 380a |
| Avion Pharmaceuticals | $47.93 | 2019 | |
| Therapeuticsmd, INC. | $44.02 | 2019-2020 | |
| Novo Nordisk INC | $42.07 | 2023-2024 | |
| Organon LLC | $38.29 | 2024 | |
| Coloplast Corp | $32.22 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.14 | 2020-2024 | |
| Biogen, INC. | $28.12 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18.88 | 2023 | Venaseal |
| Evofem Biosciences, INC. | $18.58 | 2020 | |
| Shield Therapeutics INC | $18.01 | 2023 | |
| Sumitomo Pharma America, INC. | $17.46 | 2023 | Gemtesa |
| Baxter Healthcare | $16.60 | 2019 | |
| Merck Sharp & Dohme LLC | $16.11 | 2019 | |
| Medtronic USA, INC. | $14.34 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.62 | 2019 | |
| Covidien LP | $13.28 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $12.83 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Billett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.